This inventor holds 2 USPTO granted patents. Top assignees: Ecole Normale Superieure De Lyon, Centre National De La Recherche Scientifique. Active years: 2012-2013.
Company Filing History:
2 out of 44 
1 out of 5,383 
Years Active: 2012-2013
Title: Brian B Rudkin: Innovator in Polypeptide Research
Introduction
Brian B Rudkin is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides with therapeutic applications. With a total of 2 patents, his work focuses on the modulation of cellular functions through innovative peptide sequences.
Latest Patents
Rudkin's latest patents revolve around polypeptides that exhibit modulatory effects on cells. These inventions include peptides and polypeptides with the sequence SAVTFAVCAL or variants thereof. They are capable of binding to Calcineurin and/or NS5A-TP2, which has implications for therapeutic use. The patents also cover nucleic acid sequences and vectors encoding these peptides, as well as cells that incorporate them. Furthermore, his inventions aim to induce phenotypic changes in mammalian cells, particularly by up-regulating calcineurin activity. Additionally, he has developed methods for the intracellular identification of substances that bind to calcineurin, which can modulate its physiological effects.
Career Highlights
Throughout his career, Brian B Rudkin has worked with prestigious institutions such as École Normale Supérieure de Lyon and the Centre National de la Recherche Scientifique. His research has contributed to advancements in understanding cellular mechanisms and therapeutic applications of polypeptides.
Collaborations
One of his notable collaborators is Pierre Colas, with whom he has worked on various research projects. Their combined expertise has furthered the exploration of polypeptide applications in medicine.
Conclusion
Brian B Rudkin stands out as an innovative inventor in the field of biotechnology, with a focus on polypeptides that have significant therapeutic potential. His contributions continue to influence research and development in this vital area of science.